STATIN-FIBRATE REPORT: Focus on Safety
The ACCORD study will have in excess of 5000 patients with type 2 diabetes on the combination of fenofibrate plus simvastatin vs. simvastatin alone. The primary outcome measures in this trial will include nonfatal myocardial infarction and nonfatal stroke, cardiovascular death and overall mortality. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- focus on force salesforce
- cpo focus on life science
- winners focus on winning quote
- how to focus on work
- focus on the customer examples
- customer focus on performance review
- focus on your work
- focus on middle school physics
- focus on elementary science
- focus on science curriculum
- focus on elementary
- focus on elementary chemistry